Federal Appeals Court Finds State’s Drug Price-Gouging Law Unconstitutional image

Shots: Health News From NPR, April 17, 2018
Shefali Luthra, quoting Rachel Sachs (Academic Fellow Alumna)


Read the Full Article

From the article:

States are continuing to do battle with budget-busting prices of prescription drugs. But a recent federal court decision could limit the tools available to them — underscoring the challenge states face as, in the absence of federal action, they attempt on their own to take on the powerful drug industry.

Regardless, striking down a law on constitutional grounds can be particularly discouraging, says Rachel Sachs, an associate law professor at Washington University in St. Louis, who researches drug regulations.

Read the full article here!

health care finance pharmaceuticals rachel sachs regulation